Policy Notices

• Request for Information on AHRQ Plan for Updating the Policy for Public Access to Scientific Publications and Scientific Data Resulting from AHRQ Funding
  (NOT-HS-23-011)
  Agency for Healthcare Research and Quality
  

• Updates to Funding Opportunity Terminology
  (NOT-OD-23-109)
  National Institutes of Health
  

• Reminder NIH Policies for NRSA Stipends, Compensation and Other Income
  (NOT-OD-23-111)
  National Institutes of Health
  

• Reminder: NIH Natural Disaster Policy Mississippi Severe Storms, Straight-line Winds, and Tornadoes
  (NOT-OD-23-113)
  National Institutes of Health
  

General Notices

• Update to Policy and Procedures for the Reporting of Human Subjects Enrollment Data for NIA Clinical Research Trials/Studies
  (NOT-AG-23-017)
  National Institute on Aging
  

• Notice of Informational Webinar for PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
  (NOT-GM-23-041)
  National Institute of General Medical Sciences
  

• Pilot for Improving Data about NIH R&D Contracts
  (NOT-OD-23-115)
  National Institutes of Health
  

• Findings of Research Misconduct
  (NOT-OD-23-117)
  Office of the Director, NIH
  

• Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21)
  (NOT-TR-23-012)
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Neurological Disorders and Stroke
  

• Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
  (NOT-TR-23-013)
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Neurological Disorders and Stroke
  

• Notice of Termination of PAR-22-058 Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18)
  (NOT-TR-23-014)
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Neurological Disorders and Stroke
  

• Request for Information (RFI): Inviting Comments and Suggestions on NIHs Herpes Simplex Virus Strategic Plan
  (NOT-AI-23-042)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Participation of the National Institute on Aging (NIA) in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
  (NOT-AG-23-021)
  National Institute on Aging
  

• Notice of NIAMS Withdrawal from PA-20-194 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Required"
  (NOT-AR-23-018)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed"
  (NOT-AR-23-019)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
  (NOT-CA-23-061)
  National Cancer Institute
  

• Notice to Extend the Expiration Date of PAR-20-254: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
  (NOT-HG-23-036)
  National Human Genome Research Institute
  

• Notice to Extend the Expiration Date of PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
  (NOT-HG-23-037)
  National Human Genome Research Institute
  

• Notice to Extend the Expiration Date of PAR-20-257: Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
  (NOT-HG-23-038)
  National Human Genome Research Institute
  

• Notice of Change to Submission Requirements for PAR-22-184: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
  (NOT-NS-23-081)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Changes to the PAR-22-081, Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
  (NOT-OD-23-118)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  

• Notice to Expire RFA-RM-23-008 "Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)"
  (NOT-RM-23-011)
  Office of Strategic Coordination (Common Fund)
  

• Notice to Expire RFA-RM-23-009 "Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)"
  (NOT-RM-23-012)
  Office of Strategic Coordination (Common Fund)
  

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements for HIV/AIDS and Aging Research
  (NOT-AG-23-008)
  National Institute on Aging
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Supporting Exploratory/Developmental Research Focused on NIAMS Core Mission Areas
  (NOT-AR-23-006)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements for the Dog Oncology Grant Supplement (DOGS) Program
  (NOT-CA-23-059)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology
  (NOT-CA-23-060)
  National Cancer Institute
  

• Notice of Special Interest: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
  (NOT-DK-23-013)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Funding Opportunities

• STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
  (PAR-23-144)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): September 18, 2025
  
  

• Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
  (PAR-23-149)
  National Institute of Mental Health
  Application Receipt Date(s): March 12, 2026
  
  

• Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
  (PAR-23-150)
  National Institute of Mental Health
  Application Receipt Date(s): March 12, 2026
  
  

• Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
  (PAR-23-156)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Library of Medicine
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
  (PAR-23-161)
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 22, 2023
  
  

• Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
  (PAR-23-168)
  National Institute of Mental Health
  Application Receipt Date(s): May 07, 2026
  
  

• Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
  (PAR-23-169)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 01, 2025
  
  

• Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  (PAR-23-170)
  Office of Disease Prevention
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  Office of Research on Women's Health
  Application Receipt Date(s): January 07, 2027
  
  

• Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
  (PAR-23-267)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
  (PAR-23-268)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): June 06, 2025
  
  

• Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)
  (RFA-AI-23-026)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 02, 2023
  
  

• Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed)
  (RFA-CA-23-029)
  National Cancer Institute
  Application Receipt Date(s): July 03, 2024
  
  

• SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
  (RFA-CA-23-034)
  National Cancer Institute
  Application Receipt Date(s): Not Applicable
  
  

• Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
  (RFA-CA-23-035)
  National Cancer Institute
  National Human Genome Research Institute
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  Application Receipt Date(s): August 21, 2023
  
  

• Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
  (RFA-CA-24-005)
  National Cancer Institute
  Application Receipt Date(s): October 13, 2023
  
  

• Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required)
  (RFA-DA-24-015)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 16, 2023
  
  

• Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
  (RFA-DA-24-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 13, 2023
  
  

• Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)
  (RFA-DA-24-021)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 13, 2023
  
  

• Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional)
  (RFA-DA-24-022)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 16, 2023
  
  

• Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional)
  (RFA-DA-24-023)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 16, 2023
  
  

• Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
  (RFA-DA-24-038)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 14, 2025
  
  

• Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
  (RFA-ES-23-001)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): October 02, 2023
  
  

• Renewal-Native American Tribes Outreach, Education, and Training to Enhance Food Safety and FSMA Compliance (U01) Clinical Trial Not Allowed
  (RFA-FD-23-032)
  Food and Drug Administration
  Application Receipt Date(s): June 20, 2023
  
  

• Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed)
  (RFA-HG-23-005)
  National Human Genome Research Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): November 20, 2023
  
  

• BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
  (RFA-NS-23-026)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
  (RFA-TR-23-011)
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): May 22, 2023